{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:48:34Z","timestamp":1792666114652,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.biopha.2016.03.042","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T09:03:29Z","timestamp":1460192609000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Silymarin-loaded Eudragit\u00ae RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats"],"prefix":"10.1016","volume":"81","author":[{"given":"N.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa H","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.03.042_bib0005","first-page":"8","article-title":"Preparation and in-vitro evaluation of poly-caprolactone nanoparticles containing atorvastatin calcium","volume":"4","author":"Ahmed","year":"2014","journal-title":"J. Pharm. Res. Opin."},{"key":"10.1016\/j.biopha.2016.03.042_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","article-title":"Drug delivery systems: an updated review","volume":"2","author":"Tiwari","year":"2012","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.biopha.2016.03.042_bib0015","first-page":"773","article-title":"Formulation and evaluation of sustained release ciprofloxacin hydrocloride microspheres using synthetic polymers","volume":"5","author":"Wadher","year":"2013","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0025","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2165\/00003495-200565170-00003","article-title":"Pathophysiological basis for antioxidant therapy in chronic liver disease","volume":"65","author":"Medina","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2016.03.042_bib0030","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.20683","article-title":"Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism","volume":"41","author":"Galli","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2016.03.042_bib0035","first-page":"239","article-title":"Reassessing bioavailability of silymarin","volume":"16","author":"Javed","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.biopha.2016.03.042_bib0040","first-page":"1291","article-title":"Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity","volume":"6","author":"Das","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2016.03.042_bib0045","first-page":"3333","article-title":"Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2016.03.042_bib0050","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1166\/jnn.2015.9518","article-title":"Polyethylene sebacate-silymarin nanoparticles with enhanced hepatoprotective activity","volume":"15","author":"Guhagarkar","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0055","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1039\/C3RA46093B","article-title":"Silymarin coated gold nanoparticles ameliorates CCl4-induced hepatic injury and cirrhosis through down regulation of hepatic stellate cells and attenuation of Kupffer cells","volume":"4","author":"Kabir","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2016.03.042_bib0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.biopha.2016.03.042_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1665-2681(19)31810-1","article-title":"Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats","volume":"8","author":"El-Swefy","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0070","first-page":"971","article-title":"Induction of HGF and VEGF in hepatic regeneration after hepatotoxin-induced cirrhosis in mice","volume":"58","author":"Tekkesin","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.biopha.2016.03.042_bib0075","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","article-title":"Extracellular matrix degradation in liver fibrosis: biochemistry and regulation","volume":"1832","author":"Iredale","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2016.03.042_bib0080","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3748\/wjg.v12.i19.3044","article-title":"Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models","volume":"12","author":"Nie","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0085","first-page":"1391","article-title":"Formulation and characterization of mefenamic acid loaded polymeric nanoparticles","volume":"3","author":"Patel","year":"2014","journal-title":"World J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0090","article-title":"Preparation and characterisation of ibuprofen loaded polymeric nanoparticles by solvent evaporation technique","volume":"6","author":"Sreelola","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0095","first-page":"7","article-title":"Optimization and evaluation of spray dried chitosan nanoparticles containing doxorubicin","volume":"6","author":"Patil","year":"2012","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0100","first-page":"564","article-title":"Preparation and in vitro characterization of felodipine loaded eudragit\u00aeRs100 nanoparticles","volume":"6","author":"Jana","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0105","first-page":"1228","article-title":"Box-behnken design for development and optimization of acetazolamide microspheres","volume":"5","author":"Abdallah","year":"2014","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0110","first-page":"407","article-title":"Preparation and evaluation of clotrimazole nanostructured lipid carrier for topical delivery","volume":"4","author":"Shekhawat","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0115","first-page":"259","article-title":"Formulation and evaluation of Repaglinide nanoparticles as a sustained release carriers","volume":"1","author":"Naik","year":"2012","journal-title":"Novel Sci. Int. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0120","first-page":"1001","article-title":"Statistical optimization of oral vancomycin-eudragit rs nanoparticles using response surface methodology","volume":"11","author":"Loveymi","year":"2012","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0125","first-page":"659","article-title":"Design: formulation and evaluation of ofloxacin nanoparticles","volume":"3","author":"Subramanian","year":"2012","journal-title":"Int. J. Biol. Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0130","first-page":"92","article-title":"Formulation design and evaluation of xyloglucan microsphere of silymarin","volume":"3","author":"Bhumarkar","year":"2014","journal-title":"Pharm. Innov. J."},{"key":"10.1016\/j.biopha.2016.03.042_bib0135","first-page":"349","article-title":"Cholestatic liver fibrosis in a rat model of bile duct ligation: evaluating biochemical versus histopathological changes","volume":"7","author":"Mohamed","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0140","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2016.03.042_bib0145","first-page":"147","article-title":"Formulation and evaluation of glipizide loaded nanoparticles","volume":"5","author":"Lokhande","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0150","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5185\/amlett.2012.icnano.153","article-title":"Development and characterization of atorvastatin calcium loaded chitosan nanoparticles for sustain drug delivery","volume":"3","author":"Bathool","year":"2012","journal-title":"Adv. Mater. Lett."},{"key":"10.1016\/j.biopha.2016.03.042_bib0155","first-page":"5","article-title":"Etoposide-loaded nanoparticles made from poly-e-caprolactone (pcl): formulation characterization, in vitro drug release for controlled drug delivery system","volume":"5","author":"Mallamma","year":"2014","journal-title":"Int. J. Biopharm."},{"key":"10.1016\/j.biopha.2016.03.042_bib0160","first-page":"300","article-title":"Formulation and in vitro characterization of Polymethacrylic acid nanoparticle containing frusemide","volume":"2","author":"Gaikwad","year":"2010","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0165","first-page":"345","article-title":"Preparation and evaluation of glibenclamide-loaded biodegradable nanoparticles","volume":"11","author":"Behera","year":"2012","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/15672018113109990041","article-title":"Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology","volume":"11","author":"Nandy","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2016.03.042_bib0175","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1530-0277.2010.01400.x","article-title":"Models and mechanisms of fibrosis resolution","volume":"35","author":"Snowdon","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0748233712464811","article-title":"Melatonin attenuates oxidative stress: liver damage and hepatocyte apoptosis after bile-duct ligation in rats","volume":"30","author":"Aktas","year":"2012","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.biopha.2016.03.042_bib0185","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1582-4934.2010.01098.x","article-title":"Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress","volume":"15","author":"Muchova","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2016.03.042_bib0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2007.01.015","article-title":"Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats","volume":"560","author":"Wang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2016.03.042_bib0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/1535370215627219","article-title":"Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in BDL rat model","volume":"241","author":"Mohamed","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2016.03.042_bib0200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0168-8278(01)00148-9","article-title":"Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1","volume":"35","author":"Jia","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblast\u2014like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario","volume":"29","author":"Parola","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.biopha.2016.03.042_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2010.11.016","article-title":"Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice","volume":"251","author":"Ghatak","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2016.03.042_bib0215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3346\/jkms.2011.26.8.1081","article-title":"Effects of hepatocyte growth factor on collagen synthesis and matrix metalloproteinase production in keloids","volume":"26","author":"Lee","year":"2011","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.biopha.2016.03.042_bib0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2559.2009.03391.x","article-title":"Cytokeratin expression as an aid to diagnosis in medical liver biopsies","volume":"56","author":"Bateman","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.biopha.2016.03.042_bib0225","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2016.03.042_bib0230","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells1041261","article-title":"Signals and cells involved in regulating liver regeneration","volume":"1","author":"Kang","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2016.03.042_bib0235","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.52.5.694","article-title":"Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy","volume":"52","author":"Xue","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2016.03.042_bib0240","first-page":"319","article-title":"Biochemical effects of the flavonolignane silibinin on RNA: protein and DNA synthesis in rat livers","volume":"213","author":"Sonnenbichler","year":"1986","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.biopha.2016.03.042_bib0245","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/138920112798868818","article-title":"Silymarin in the prevention and treatment of liver diseases and primary liver cancer","volume":"13","author":"Feher","year":"2012","journal-title":"Curr. Pharm. Biotechnol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119664","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000}},{"DOI":"10.1016\/j.biopha.2026.119664","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216302426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216302426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:31:54Z","timestamp":1788877914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216302426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":49,"alternative-id":["S0753332216302426"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.03.042","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silymarin-loaded Eudragit\u00ae RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}